Elucidating the Mechanism of Buyanghuanwu Decoction Acting on Pulmonary Fibrosis Based on Network Pharmacology and Animal Studies


Цитировать

Полный текст

Аннотация

Background and Objective:Buyanghuanwu Decoction (BYHWD) is a clinically proven prescription effective in treating pulmonary fibrosis (PF), but the molecular mechanism underlying its action remains unclear. The network pharmacology analysis was performed to elucidate the acting substances and related pathways of BYHWD in treating bleomycin (BLM) induced PF mouse.

Methods:First, the pharmacologically active components and corresponding targets in BYHWD were identified through the TCMSP database and literature review. Second, PF-related targets were identified through the DisGeNet database. Then, the components-targets network of BYHWD in PF treatment was constructed using Cytoscape. The DAVID database was used for the enrichment analysis of GO terms and KEGG pathways. At last, the therapeutic effect of BYHWD on BLMinduced PF mice were verified, and the mRNA and protein expression of related targets was determined through RT-PCR and western blotting, respectively.

Results:The core component-target network contained 58 active components and 147 targets. Thirty-nine core targets were mainly involved in the regulation of biological functions and KEGG pathways, such as the positive regulation of nitric oxide biosynthesis and the TNF signaling pathway. These core targets were obtained through enrichment analysis. Moreover, animal studies revealed that BYHWD down-regulated the mRNA expression levels of TNF, IL-6, IL-1β, and NOS2 and inhibited NF-κB and p38 phosphorylation.

Conclusion:The effects of BYHWD on PF mice are therapeutic, and its anti-PF mechanism mainly involves the effects on inflammatory factors and the NF-κB/p38 pathway.

Об авторах

Qichang Xing

Department of Clinical Pharmacy, Xiangtan Central Hospital

Автор, ответственный за переписку.
Email: info@benthamscience.net

Xiang Liu

Department of Clinical Pharmacy, Xiangtan Central Hospital

Автор, ответственный за переписку.
Email: info@benthamscience.net

Zheng Liu

Department of Clinical Pharmacy, Xiangtan Central Hospital

Email: info@benthamscience.net

Qingzi Yan

Department of Clinical Pharmacy, Xiangtan Central Hospital

Email: info@benthamscience.net

Yixiang Hu

Department of Clinical, Xiangtan Central Hospital

Email: info@benthamscience.net

Wencan Li

Department of Clinical, Xiangtan Central Hospital

Email: info@benthamscience.net

Ke Peng

Department of Clinical, Xiangtan Central Hospital

Email: info@benthamscience.net

Список литературы

  1. Kaur, A.; Mathai, S.K.; Schwartz, D.A. Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment. Front. Med., 2017, 4, 154. doi: 10.3389/fmed.2017.00154 PMID: 28993806
  2. Hutchinson, J.; Fogarty, A.; Hubbard, R.; McKeever, T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur. Respir. J., 2015, 46(3), 795-806. doi: 10.1183/09031936.00185114 PMID: 25976683
  3. Nalysnyk, L.; Cid-Ruzafa, J.; Rotella, P.; Esser, D. Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature. Eur. Respir. Rev., 2012, 21(126), 355-361. doi: 10.1183/09059180.00002512 PMID: 23204124
  4. Jiang, H.Y.; Yang, H.; Dai, Q.; Wu, X.H.; Tanghao, Y.N.; Wang, F.; Du, Q.Y. Clinical trial of buyang huanwutang in treatment of connective tissue disease-associated pulmonary fibrosis with syndrome of Qi deficiency and blood stasis. Zhongguo Shiyan Fangjixue Zazhi, 2022, 28(21), 104-111.
  5. Xiao, M.F.; Liu, J.L.; Yang, Y.T.; Liu, W.L.; Deng, K.W. Current research situation of Buyang Huanwu Decoction and its development of new medical invention. Chin. Tradit. Herbal Drugs, 2018, 49(7), 1688-1694.
  6. Chen, H.; Song, H.; Liu, X.; Tian, J.; Tang, W.; Cao, T.; Zhao, P.; Zhang, C.; Guo, W.; Xu, M.; Lu, R. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis. Biomed. Pharmacother., 2017, 95, 461-468. doi: 10.1016/j.biopha.2017.08.102 PMID: 28865366
  7. Ru, J.; Li, P.; Wang, J.; Zhou, W.; Li, B.; Huang, C.; Li, P.; Guo, Z.; Tao, W.; Yang, Y.; Xu, X.; Li, Y.; Wang, Y.; Yang, L. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform., 2014, 6(1), 13. doi: 10.1186/1758-2946-6-13 PMID: 24735618
  8. Huang, J.W.; Gao, H.W.; Duan, J.F. Research on chemical composition and pharmacological effects of geosaurus. Guiding J. Tradit. Chin. Med. Pharm., 2018, 12(24), 104-107.
  9. Piñero, J.; Bravo, À.; Queralt-Rosinach, N.; Gutiérrez-Sacristán, A.; Deu-Pons, J.; Centeno, E.; García-García, J.; Sanz, F.; Furlong, L.I. DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res., 2017, 45(D1), D833-D839. doi: 10.1093/nar/gkw943 PMID: 27924018
  10. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res., 2003, 13(11), 2498-2504. doi: 10.1101/gr.1239303 PMID: 14597658
  11. Szklarczyk, D.; Gable, A.L.; Lyon, D.; Junge, A.; Wyder, S.; Huerta-Cepas, J.; Simonovic, M.; Doncheva, N.T.; Morris, J.H.; Bork, P.; Jensen, L.J.; Mering, C. STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res., 2019, 47(D1), D607-D613. doi: 10.1093/nar/gky1131 PMID: 30476243
  12. Dennis, G., Jr; Sherman, B.T.; Hosack, D.A.; Yang, J.; Gao, W.; Lane, H.C.; Lempicki, R.A. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol., 2003, 4(5), P3. doi: 10.1186/gb-2003-4-5-p3 PMID: 12734009
  13. Li, X.H.; Xiao, T.; Yang, J.H.; Qin, Y.; Gao, J.J.; Liu, H.J.; Zhou, H.G. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway. Respir. Res., 2018, 19(1), 111.
  14. Ashcroft, T.; Simpson, J.M.; Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 1988, 41(4), 467-470. PMID: 3366935
  15. Zhang, Y.; Lu, P.; Qin, H.; Zhang, Y.; Sun, X.; Song, X.; Liu, J.; Peng, H.; Liu, Y.; Nwafor, E.O.; Li, J.; Liu, Z. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. Biomed. Pharmacother., 2021, 133111072. doi: 10.1016/j.biopha.2020.111072 PMID: 33378971
  16. Xin, L.L.; Jiang, M.; Zhang, G.; Gong, J.N. Efficacy and safety of Danhong injection for idiopathic pulmonary fibrosis: Meta-analysis. Zhongguo Zhongyao Zazhi, 2016, 41(20), 3859-3865. PMID: 28929667
  17. Yu, X.; Yang, S.; Xie, Y.; Li, J. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial. J. Integr. Med., 2020, 18(2), 163-168. doi: 10.1016/j.joim.2019.12.005 PMID: 31928920
  18. Yu, X.; Zhang, Y.; Yang, X.; Zhang, X.; Wang, X.; Liu, X.; Yan, Y. The influence of buqihuoxuetongluo formula on histopathology and pulmonary function test in bleomycin-induced idiopathic pulmonary fibrosis in rats. Evid. Based Complement. Alternat. Med., 2018, 2018, 1-13. doi: 10.1155/2018/8903021 PMID: 30046348
  19. Huang, H.; Peng, X.; Zhong, C. Idiopathic pulmonary fibrosis: The current status of its epidemiology, diagnosis, and treatment in China. Intractable Rare Dis. Res., 2013, 2(3), 88-93. doi: 10.5582/irdr.2013.v2.3.88 PMID: 25343109
  20. Yang, Y.; Zengtao, S.; Liqing, S.; Yanping, Z.; Zhaoshan, Z.; Shunan, Z.; Enxiang, C. Effects of Feiwei granules in the treatment of idiopathic pulmonary fibrosis: a randomized and placebo-controlled trial. J. Tradit. Chin. Med., 2016, 36(4), 427-433. doi: 10.1016/S0254-6272(16)30058-9 PMID: 28459237
  21. Zhang, S.; Wu, H.; Liu, J.; Gu, H.; Li, X.; Zhang, T. Medication regularity of pulmonary fibrosis treatment by contemporary traditional Chinese medicine experts based on data mining. J. Thorac. Dis., 2018, 10(3), 1775-1787. doi: 10.21037/jtd.2018.03.11 PMID: 29707332
  22. Li, C.; Zhang, W.J.; Frei, B. Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction. Redox Biol., 2016, 9, 104-113. doi: 10.1016/j.redox.2016.06.006 PMID: 27454768
  23. Boots, A.W.; Veith, C.; Albrecht, C.; Bartholome, R.; Drittij, M.J.; Claessen, S.M.H.; Bast, A.; Rosenbruch, M.; Jonkers, L.; van Schooten, F.J.; Schins, R.P.F. The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice. BMC Pulm. Med., 2020, 20(1), 112. doi: 10.1186/s12890-020-1142-x PMID: 32349726
  24. Ulusoy, H.G.; Sanlier, N. A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities. Crit. Rev. Food Sci. Nutr., 2020, 60(19), 3290-3303. doi: 10.1080/10408398.2019.1683810 PMID: 31680558
  25. Aziz, N.; Kim, M.Y.; Cho, J.Y. Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. J. Ethnopharmacol., 2018, 225, 342-358. doi: 10.1016/j.jep.2018.05.019 PMID: 29801717
  26. Liu, H.; Yu, H.; Cao, Z.; Gu, J.; Pei, L.; Jia, M.; Su, M. Kaempferol modulates autophagy and alleviates silica-induced pulmonary fibrosis. DNA Cell Biol., 2019, 38(12), 1418-1426. doi: 10.1089/dna.2019.4941 PMID: 31560574
  27. Liang, Q.; Cai, W.; Zhao, Y.; Xu, H.; Tang, H.; Chen, D.; Qian, F.; Sun, L. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Pharmacol. Res., 2020, 158104884. doi: 10.1016/j.phrs.2020.104884 PMID: 32428667
  28. Li, C.; Sun, X.; Li, A.; Mo, M.; Zhao, Z. S-Allylmercaptocysteine attenuates Bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-β1/Smad and oxidative stress pathways. Int. Immunopharmacol., 2020, 79106110. doi: 10.1016/j.intimp.2019.106110 PMID: 31874367
  29. Malaviya, R.; Laskin, J.D.; Laskin, D.L. Anti-TNFα therapy in inflammatory lung diseases. Pharmacol. Ther., 2017, 180, 90-98. doi: 10.1016/j.pharmthera.2017.06.008 PMID: 28642115
  30. Epstein Shochet, G.; Bardenstein-Wald, B.; McElroy, M.; Kukuy, A.; Surber, M.; Edelstein, E.; Pertzov, B.; Kramer, M.R.; Shitrit, D. Hypoxia Inducible Factor 1A Supports a Pro-Fibrotic Phenotype Loop in Idiopathic Pulmonary Fibrosis. Int. J. Mol. Sci., 2021, 22(7), 3331. doi: 10.3390/ijms22073331 PMID: 33805152
  31. Mukhopadhyay, S.; Hoidal, J.R.; Mukherjee, T.K. Role of TNFα in pulmonary pathophysiology. Respir. Res., 2006, 7(1), 125. doi: 10.1186/1465-9921-7-125 PMID: 17034639
  32. Gad, E.S.; Salama, A.A.A.; El-Shafie, M.F.; Arafa, H.M.M.; Abdelsalam, R.M.; Khattab, M. The anti-fibrotic and anti-inflammatory potential of bone marrow–derived mesenchymal stem cells and nintedanib in bleomycin-induced lung fibrosis in rats. Inflammation, 2020, 43(1), 123-134. doi: 10.1007/s10753-019-01101-2 PMID: 31646446
  33. Liu, P.; Yang, S.; Wang, Z.; Dai, H.; Wang, C. Feasibility and mechanism analysis of shenfu injection in the treatment of idiopathic pulmonary fibrosis. Front. Pharmacol., 2021, 12670146. doi: 10.3389/fphar.2021.670146 PMID: 34393772
  34. Lappalainen, U.; Whitsett, J.A.; Wert, S.E.; Tichelaar, J.W.; Bry, K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell Mol. Biol., 2005, 32(4), 311-318. doi: 10.1165/rcmb.2004-0309OC PMID: 15668323
  35. Chung, M.P.; Monick, M.M.; Hamzeh, N.Y.; Butler, N.S.; Powers, L.S.; Hunninghake, G.W. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am. J. Respir. Cell Mol. Biol., 2003, 29(3), 375-380. doi: 10.1165/rcmb.2003-0029OC PMID: 12676806
  36. Noguchi, S.; Yatera, K.; Wang, K.Y.; Oda, K.; Akata, K.; Yamasaki, K.; Kawanami, T.; Ishimoto, H.; Toyohira, Y.; Shimokawa, H.; Yanagihara, N.; Tsutsui, M.; Mukae, H. Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice. Respir. Res., 2014, 15(1), 92. doi: 10.1186/s12931-014-0092-3 PMID: 25092105

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024